Actavis Recalls Dextroamphetamine Sulfate Capsules for Dissolution Failures
Actavis Inc is recalling Dextroamphetamine Sulfate Extended-Release Capsules because they failed to meet dissolution specifications. The recall covers 8,062 units distributed nationwide.
- Product
- DEXTROAMPHETAMINE SULFATE — DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
- Category
- Drug
- Distribution
- Distributed nationwide